These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1133 related articles for article (PubMed ID: 15866165)

  • 1. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
    Glass DA; Bialek P; Ahn JD; Starbuck M; Patel MS; Clevers H; Taketo MM; Long F; McMahon AP; Lang RA; Karsenty G
    Dev Cell; 2005 May; 8(5):751-64. PubMed ID: 15866165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.
    Glass DA; Karsenty G
    Ann N Y Acad Sci; 2006 Apr; 1068():117-30. PubMed ID: 16831912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.
    Day TF; Guo X; Garrett-Beal L; Yang Y
    Dev Cell; 2005 May; 8(5):739-50. PubMed ID: 15866164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of beta-catenin in postnatal bone acquisition.
    Holmen SL; Zylstra CR; Mukherjee A; Sigler RE; Faugere MC; Bouxsein ML; Deng L; Clemens TL; Williams BO
    J Biol Chem; 2005 Jun; 280(22):21162-8. PubMed ID: 15802266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBF2 regulates osteoblast-dependent differentiation of osteoclasts.
    Kieslinger M; Folberth S; Dobreva G; Dorn T; Croci L; Erben R; Consalez GG; Grosschedl R
    Dev Cell; 2005 Dec; 9(6):757-67. PubMed ID: 16326388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
    Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
    J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/beta-catenin--a canonical tale of cell-fate choice in the vertebrate skeleton.
    Kolpakova E; Olsen BR
    Dev Cell; 2005 May; 8(5):626-7. PubMed ID: 15866155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.
    Hill TP; Später D; Taketo MM; Birchmeier W; Hartmann C
    Dev Cell; 2005 May; 8(5):727-38. PubMed ID: 15866163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
    Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
    Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential roles of Hedgehog and Wnt signaling in osteoblast development.
    Hu H; Hilton MJ; Tu X; Yu K; Ornitz DM; Long F
    Development; 2005 Jan; 132(1):49-60. PubMed ID: 15576404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signaling and osteoblastogenesis.
    Bodine PV; Komm BS
    Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
    Mansukhani A; Ambrosetti D; Holmes G; Cornivelli L; Basilico C
    J Cell Biol; 2005 Mar; 168(7):1065-76. PubMed ID: 15781477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
    Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of bone metabolism by Wnt signals.
    Kobayashi Y; Uehara S; Udagawa N; Takahashi N
    J Biochem; 2016 Apr; 159(4):387-92. PubMed ID: 26711238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass.
    Wang FS; Lin CL; Chen YJ; Wang CJ; Yang KD; Huang YT; Sun YC; Huang HC
    Endocrinology; 2005 May; 146(5):2415-23. PubMed ID: 15677765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo analysis of Wnt signaling in bone.
    Glass DA; Karsenty G
    Endocrinology; 2007 Jun; 148(6):2630-4. PubMed ID: 17395705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells.
    Billiard J; Way DS; Seestaller-Wehr LM; Moran RA; Mangine A; Bodine PV
    Mol Endocrinol; 2005 Jan; 19(1):90-101. PubMed ID: 15388793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
    Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
    Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.